The E-cadherin/catenin complex in invasion and metastasis.
Bracke
M E
ME
Department of Radiotheraphy Nuclear Medicine and Experimental Cancerology, University Hospital, Gent, Belgium.
Van Roy
F M
FM
Mareel
M M
MM
D000230:Adenocarcinoma / Q000473:pathology; D000818:Animals; D001943:Breast Neoplasms / Q000473:pathology; D015820:Cadherins / Q000737:chemistry / Q000502:physiology*; D016764:Cell Polarity; D003598:Cytoskeletal Proteins / Q000737:chemistry / Q000502:physiology*; D003599:Cytoskeleton / Q000378:metabolism; D051180:Desmoplakins; D004285:Dogs; D004848:Epithelium / Q000378:metabolism; D005326:Fetal Proteins / Q000378:metabolism; D047309:Flavones; D005419:Flavonoids / Q000494:pharmacology; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D018969:Insulin-Like Growth Factor Binding Proteins / Q000494:pharmacology; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology; D046911:Macromolecular Substances; D005810:Multigene Family; D009361:Neoplasm Invasiveness / Q000517:prevention & control; D009362:Neoplasm Metastasis / Q000517:prevention & control; D009363:Neoplasm Proteins / Q000502:physiology; D011487:Protein Conformation; D017526:Receptor, IGF Type 1 / Q000187:drug effects / Q000502:physiology; D013329:Structure-Activity Relationship; D013629:Tamoxifen / Q000494:pharmacology; D015534:Trans-Activators; D014212:Tretinoin / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects / Q000378:metabolism; D051178:alpha Catenin; D051176:beta Catenin
C495273:CTNNA1 protein, human; C495270:CTNNB1 protein, human; D015820:Cadherins; D003598:Cytoskeletal Proteins; D051180:Desmoplakins; D005326:Fetal Proteins; D047309:Flavones; D005419:Flavonoids; D018969:Insulin-Like Growth Factor Binding Proteins; D046911:Macromolecular Substances; D009363:Neoplasm Proteins; D015534:Trans-Activators; D051178:alpha Catenin; D051176:beta Catenin; D013629:Tamoxifen; D014212:Tretinoin; D007334:Insulin-Like Growth Factor I; D017526:Receptor, IGF Type 1; C059006:tangeretin